ABSTRACT: Atypical Aeromonas salmonicida strains comprise a heterogeneous group in terms of molecular and phenotypic characteristics. They cause various conditions of ulcer diseases or atypical furunculosis and are being isolated in increasing number from various fish species and geographical areas. Several marine fish species susceptible to atypical A. salmonicida, including spotted wolffish Anarhichas minor O., are now being farmed and new vaccines may be needed. A commercial furunculosis vaccine for salmon is reported to protect wolffish poorly against experimental challenge with atypical A. salmonicida. The protective antigen(s) in furunculosis vaccines is still unclear, but in oiladjuvanted vaccine for Atlantic salmon Salmo salar L., the surface A-layer was shown to be important for protection. In spotted wolffish, the efficacy of atypical furunculosis vaccines seems to vary with the atypical A. salmonicida strains used as bacterin in the vaccine. In the present study we investigated whether differences in the A-layer protein among atypical strains might be responsible for the observed variation in vaccine efficacy. Atypical A. salmonicida strains from 16 fish species in 11 countries were compared by genome polymorphism analysis using amplified fragment length polymorphism (AFLP) fingerprinting and by comparative sequencing of the vapA genes encoding the A-protein. The A-protein sequences appeared to be highly conserved except for a variable region between Residues 90 to 170. Surprisingly, the grouping of strains based on AFLP-or A-protein sequence similarities was consistent. In addition, serological differences in the A-protein among the strains were demonstrated by an A-protein-specific monoclonal antibody. Vaccines based on atypical A. salmonicida strains possessing genetically and serologically different A-layer proteins were shown to result in significantly different protection in spotted wolffish.
INTRODUCTION
Aeromonas salmonicida ssp. salmonicida comprises a homogeneous group, referred to as typical A. salmonicida, and causes furunculosis mostly in salmonid fishes. Atypical A. salmonicida strains that cause various conditions of ulcer diseases or atypical furunculosis in both salmonid and marine fish species are heterogeneous in terms of molecular and phenotypic characteristics (review by Wiklund & Dalsgaard 1998) . Several subspecies of A. salmonicida, i.e. ssp. achromogenes, masoucida, smithia and pectinolytica (Smith 1963 , Kimura 1969 , Austin et al. 1989 , Pavan et al. 2000 have been described. In addition, an increasing number of atypical isolates that do not fit into any of these subspecies are reported (reviewed in Wiklund & Dalsgaard 1998) . Molecular techniques are now being used to complement the traditional phenotypic methods for classification of atypical A. salmonicida strains. Random amplified polymorphic DNA analysis (RAPD) (Kwon al. 1997 , O'hIci et al. 2000 , ribotyping (Hänni-nen & Hirvelä-Koski 1997) , PCR-typing (Høie et al. 1999) , plasmid profiling (Sørum et al. 2000) , restriction fragment analysis by pulse-field gel electrophoresis (PFGE) (Umelo & Trust 1998 , O'hIci et al. 2000 and amplified fragment length polymorphism analysis (AFLP) (Lund et al. 2002a ) have been used to demonstrate genetic diversity among the atypical strains. However, these methods are not comparable (Austin et al. 1998) , and a reliable method for classification of atypical strains is still lacking.
Several marine fish species susceptible to atypical Aeromonas salmonicida infection are now being farmed, and vaccine development will be necessary. It is not known if species-specific vaccines are needed, or if vaccines that protect against all genotypes of atypical A. salmonicida in various fish species can be developed. For the past 10 yr furunculosis in Atlantic salmon Salmo salar L. has been successfully controlled by the use of highly efficient oil-adjuvanted vaccines. Commercial salmon vaccines have been shown to protect against infection with atypical A. salmonicida in salmon (Gudmundsdottir & Gudmundsdottir 1997 ), but not in spotted wolffish Anarhichas minor O. (Lund et al. 2002b ). However, in Atlantic salmon a commercial furunculosis vaccine was not as efficient as an autogenous vaccine (Gudmundsdottir & Gudmundsdottir 1997) . The reason for the observed variation in efficacy of the furunculosis vaccine when challenged with various atypical strains is not known, but may be due to variation in protective antigens. Several components of A. salmonicida have been suggested as protective antigens. Among these is the surface A-layer composed of a single protein subunit, the A-protein, encoded by the virulence array protein gene A (vapA) (Chu et al. 1991) . A correlation between the presence of the Alayer and virulence has been suggested (Kay et al. 1981 , Austin & Austin 1993 ), but nevertheless non-virulent strains possessing an A-layer and virulent strains with no detectable A-layer have been reported (Ellis et al. 1988 , Olivier 1990 , Austin & Austin 1993 . The Alayer is also reported to protect the bacteria from the bactericidal activity of both immune and non-immune serum and probably also from the lethal effects of phagocytic cells (review by Secombes & Olivier 1997) .
The A-layer protein is highly immunogenic, but antibody responses to this antigen could not be correlated with protection (Olivier et al. 1985 , Hastings & Ellis 1990 , Lund et al. 1991 , Bjørnsdottir et al. 1992 . However, goldfish with high levels of natural antibody activity against the A-layer protein were largely protected against experimental infection with an atypical strain of Aeromonas salmonicida (Sinyakov et al. 2002) . Furthermore, a significant positive correlation between survival rates and corresponding antibody levels to the A-layer protein was found in Atlantic salmon vaccinated with commercial oil-adjuvanted furunculosis vaccines (Midtlyng et al. 1996) . Also, in these vaccines, the A-layer protein appeared to be crucial for protection since no protection was obtained with an A-layer-negative vaccine strain (Lund et al. 2003) In farmed spotted wolffish, experimental vaccines for atypical furunculosis based on genetically different strains determined by AFLP-fingerprinting were shown to result in significantly different protection (Lund et al. 2002a ). However, protection could not be correlated to specific genes or protective antigens. Thus, the aim of this study was to investigate if variation in the A-protein could be related to differences in vaccine efficacy. Atypical Aeromonas salmonicida strains from 16 fish species and 11 countries were subjected to both serological and genetic characterisation using A-protein-specific monoclonal and polyclonal antibodies, AFLP-fingerprinting and comparative sequencing of vapA genes encoding the A-protein.
Finally, vaccine efficacy in spotted wolffish was correlated to molecular differences in the A-proteins.
MATERIALS AND METHODS
Bacterial strains and growth conditions. This study comprised a collection of 36 strains of Aeromonas salmonicida (see Table 2 ) from 16 fish species and 11 countries, including the subspecies reference strains salmonicida 4010, 4014 and 4112, smithia 4109, masoucida 4110, achromogenes 4111 and pectinolytica 4113. The atypical strains from salmonids, cod Gadus morhua, halibut Hippoglossus hippoglossus, turbot Scophthalmus maximus and spotted wolffish were mostly from Norway and Iceland, but additional strains from several other marine fish species from geographically more distant countries were also included; 18 of the atypical strains, including 6 strains previously characterised as the subspecies achromogenes, were a gift from Dr. Bjarnheidur Gudmundsdottir (Institute of Experimental Pathology, University of Iceland), while the rest were from the strain collection at Norwegian Institute of Fisheries and Aquaculture Research.
The bacterial strains were stored at -80°C in 15% glycerol until used. They were grown with gentle shaking at 12°C in brain-heart infusion broth (BHI, Difco) supplemented with 2% NaCl. The strains used for challenge were grown for 24 h, harvested by centrifugation, and resuspended in 2% NaCl to OD 600nm = 1 (optical density at 600 nm ). For vaccine purposes, the bacterial cultures were inactivated with 0.5% vol/vol formaldehyde solution (37%). BHI agar (Oxoid) supplemented with 2% NaCl and 0.005% Coomassie brilliant blue R (Sigma), and blood agar base No. 2 (Oxoid) supplemented with 2% human red blood cells and 1.5% NaCl were used for isolation of the bacteria from the head kidney of dead fish.
Characterisation of A-layer proteins.
A-layer-producing strains were verified with an A-protein-specific polyclonal rabbit antiserum (R-anti-A) produced in our laboratory against a subspecies salmonicida strain. The A-protein-specific monoclonal antibody Mab1B2 (Bjørnsdottir et al. 1992) , which is reactive to whole cells as well as epitopes in Western blot, was used to detect amino acid sequence variation in the A-layer protein among the strains. Whole-cell lysates of the atypical Aeromonas salmonicida strains were obtained from cells in 1 ml overnight culture. After centrifugation, the cells were suspended in 1 ml 20 mM Tris HCl pH 8.0 and mixed with sample buffer (10 mM Tris HCl pH 8.0, 5% sodium dodecyl sulphate [BIORAD] , 10% mercaptoethanol [ROTH], 4% glycerol [Sigma] ) in a proportion of 1:1 before being boiled for 5 min. Separation of cell lysates and transfer of proteins (Western blot) onto 0.45 µm nitro-cellulose membranes (Trans-Blot ® , BIORAD) were performed in 12% Tris HCl Criterion gels in a Criterion™ cell and Criterion™ blotter (BIORAD) according to the BIORAD instruction manual. The membranes were blocked with phosphate-buffered saline (PBS) containing 0.05% Tween 20 (PBS-Tween) and 5% non-fat dry milk. Primary antisera were either R-anti-A or Mab1B2, and secondary antibodies were goat anti-rabbit (DAKO) or goat anti-mouse immunoglobulins (Sigma), both conjugated with alkaline phosphatase. The membranes were incubated in appropriate dilutions of the various antibodies in PBS-Tween with 0.5% nonfat dry milk for 60 min at room temperature with gentle shaking, and washed 3 ¥ 10 min with PBS-Tween between each incubation step. Finally, the membranes were stained by adding the substrate nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indolylphosphate (NBT and BCIP; Gibco BRL) in substrate buffer (0.1 M Tris HCl pH 9.5, 0.1 M NaCl and 50 mM MgCl 2 ) as recommended by the producer.
Genomic DNA extraction. Cells were harvested from overnight cultures by centrifugation of 1 ml at 14 000 ¥ g for 3 min followed by extraction of genomic DNA by the use of GenomicPrep™ (Amersham Pharmacia Biotech). High-quality unsheared genomic DNA was confirmed on a 1% agarose gel. The DNA concentration was determined by measuring absorbance at 260 nm in a spectrophotometer (1 A 260 unit = 50 µg DNA ml -1 ). The DNA preparations were diluted in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) to 10 µg ml -1 and used for both AFLP-fingerprinting and DNAsequencing.
AFLP-analysis. Amplified fragment length polymorphism analysis was performed using an AFLP™ Microbial fingerprinting kit (PE Applied Biosystems) as previously described (Lund et al. 2002a) . Oligonucleotide adaptors, primers and amplification mixture were provided by the producer. Briefly, genomic DNA was digested with restriction enzymes EcoRI and MseI (New England BioLabs) followed by ligation of double-stranded restriction-halfsite-specific adaptors to the restriction fragments using T4 DNA ligase (Promega). A preselective amplification of the restriction fragments was performed with a primer pair complementary to the adaptors, followed by selective amplification using the EcoRI-A/MseI-T primer pair. During the selective amplification, the PCR products were labelled with the 5' fluorescent dye-label on the EcoRI-A primer for use with ABI Prism™ detection technology. Prior to gel-loading, GeneScan-500 was added to each sample as an internal lane-size standard to size all amplification fragments accurately. The PCR products were separated on an ABI PRISM 3100-Avant genetic analyser (PE Applied Biosystems), and the results were analysed with ABI Prism™ GeneScan ® Analysis and Genotyper ® 2.0 software (PE Applied Biosystems). The strains produced a total of 75 amplification fragments evenly dispersed from 50 to 495 bases. Each strain was visually coded for the presence (Code 1) and absence (Code 0) of each DNA fragment, and an AFLP-based similarity dendrogram was derived from unweighted averagepair group cluster analysis using the Pearson similarity coefficient (Wilkinson 1999) Comparative DNA-sequencing of vapA genes. The vapA gene of Aeromonas salmonicida ssp. salmonicida Strain A450, encoding an A-protein of 502 residues including a 21 amino acid-signal peptide (Chu et al. 1991, GenBank Accession No. M64655) , was used to synthesise 6 forward primers and 1 reverse primer (Eurogentec) ( Table 1 ). The primer pair F1-R1 was used to produce 1565 bp PCR fragments from all strains encoding the mature A-protein. The amplifica- tion was performed using GeneAmp PCR System 2400 (Perkin Elmer). The 50 µl reaction mixture contained 25 ng genomic DNA, 250 µM dNTPs (Sigma), 1.25 Units Taq DNA polymerase, and 5 µl 10 ¥ Taq DNA polymerase buffer (Promega), 2 mM MgCl 2 , 100 ng of each primer and 50 µM tetramethylammoniumchloride. Amplification conditions were 29 cycles of 10 s at 95°C, 10 s at 50°C and 60 s at 72°C, and a final extension of 3 min at 72°C. The PCR products were purified by separation on 0.8% agarose gel and purified from the gel using QIAEX ® II gel extraction kit (QIAGEN). The forward primers were used for DNA-sequencing 1565 bp PCR fragments from 4 of the atypical Aeromonas salmonicida strains. Sequencing was performed with an ABI PRISM 3100-Avant genetic analyser using the dye-terminator cycle-sequencing method as described in the producer's protocol (ABI PRISM BigDye DNA sequencing kit). The region of the vapA gene encoding the mature A-protein was obtained by primer walking, and a revealed variable region was sequenced from the entire strain collection using the F2 primer (Table 2 ). Multiple sequence alignment was produced using Clustal X (1.8) (Thompson et al. 1997) , and an unrooted similarity dendrogram based on sequence comparison was derived by the bootstrap neighbourjoining method (Felsenstein 1985) .
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Fish. Spotted wolffish with an approximate weight of 25 g were from Troms Steinbit AS, Rubbestad, Norway. The vaccination and challenge experiments were performed at the Aquaculture Research Station in Tromsø, Norway. Throughout the whole experimental period, the fish were kept at 12°C with 24 h continuous light. Prior to marking, vaccination or challenge, the fish were anaesthetized with benzocain (50 mg l -1 water). Different groups were marked with Visible Implant Fluorescent Elastomer (Northwest Marine Technology) at the basis of the dorsal fin.
Vaccines and vaccination. Four atypical Aeromonas salmonicida strains isolated from diseased spotted wolffish were used in the vaccines. Strains 4059, 4065 and 4067 were found to be serologically homogenous, but Strain 4128 was different (see Table 2 ). Furthermore, according to the A-protein similarity dendrogram based on multiple alignment of partial sequences (Residues 63 to 208) of the gene, Strains 4059, 4065 and 4067 were in the same cluster, whereas Strain 4128 belonged to a closely related cluster (see Fig. 4 ). Only the cell fractions of formalin-inactivated bacterial cultures were used as vaccine antigens. After centrifugation, the pellet was suspended in 0.9% NaCl to an appropriate bacterial concentration before being emulsified with the mineral oil-adjuvant used in the ALPHA JECT™ 1200 furunculosis vaccine for salmon (Alpharma AS). The amount of bacterial cells used in the wolffish vaccines corresponded to that in ALPHA JECT™ 1200, which was included in the experiment.
The fish were vaccinated by intraperitoneal (i.p.) injection of 0.1 ml vaccine; 5 groups of 80 fish were each vaccinated with 1 of the vaccines, while a control group of 80 fish received 0.9% NaCl emulsified in oiladjuvant. During the immunisation period of 9 wk, the groups were kept in separate raceways (40 ¥ 20 ¥ 220 cm).
Prechallenge , and achieved 94% mortality; this was the preferred dose for challenge of the vaccinated fish.
We transferred and redistributed the fish 1 wk prior to challenge, with 40 fish per group into 2 tanks A and B (500 l each). The fish were i.p.-challenged with 0.1 ml of atypical Aeromonas salmonicida 4067 containing 32 cfu, as determined by plate-counts. Mortality was recorded daily, and the cause of death verified by isolation of A. salmonicida bacteria from the head kidney. Relative percent survival (RPS) was calculated for each group on the last day of the experiment according to the formula RPS = (1 -%mortality in vaccinated group/%mortality in control group) ¥ 100%.
Logistic regression (Type III sum-of-squares) in the GENMOD procedure of SAS 8.1 (SAS Institute 1993) was used to determine statistical differences in mortality between the 2 tanks and between the vaccinated and unvaccinated groups. Comparison of the vaccines was based on the results from duplicate tanks. Each vaccine was individually compared wiht the others, and the results were considered significant if p < 0.05.
RESULTS
The polyclonal antibody R-anti-A was used to determine A-layer-producing strains with Western blot. In addition to the atypical strains from cod (4102) and Atlantic salmon (4120) the reference strains of subspecies salmonicida 4010 and 4112, masoucida 4110, achromogenes 4111 and pectinolytica 4113 were shown to be A-layer-deficient (Table 2) . Thus, the Aprotein-specific Mab1B2 did not react with these strains, nor with the subspecies reference strain smithia 4109, 4 of the 6 wolffish strains, or the flounder strain 4122 (Table 2) , thereby demonstrating antigenic differences in the A-layer protein among the strains.
Genome polymorphism among the strains was demonstrated by AFLP fingerprinting and is presented as a similarity dendrogram in Fig. 1 . Comparison using a cluster delineation of 70% similarity resulted in a grouping of the strains into 5 clusters (A to E). A large cluster (A) contained 19 strains, while 4 smaller clusters contained from 2 to 4 strains. In addition, 5 strains were unclustered, including the subspecies reference strains pectinolytica 4113 and smithia 4109 and 3 strains from goldfish, dab and carp, respectively. The achromogenes reference Strain 4111 appeared in a cluster (A) with 5 of the 6 strains previously classified as subspecies achromogenes (Table 2 ) in addition to all 6 wolffish strains, 3 halibut strains and 3 strains from turbot, char and salmon, respectively. The typical Aeromonas salmonicida reference strains 4010, 4014 and 4112 all appeared in a cluster (D) with an atypical flounder strain 4122, while the masoucida reference strain clustered with 2 atypical strains from halibut and ling cod. For turbot, 3 strains appeared in 1 cluster (B), and the strain from koi carp and char previously classified as subspecies achromogenes (Table 2 ) appeared in another cluster (C).
In order to assess variation in the A-protein, the entire vapA gene of 4 atypical strains from char (4043), halibut (4050), spotted wolffish (4065) and turbot (4092) was sequenced. The deduced protein sequences were compared by sequence alignment with the reference sequence of the typical strain A450 (GenBank M64655) (Fig. 2) . The A-protein sequences appeared very conserved, displaying from 90 to 94% protein sequence identity compared to the typical reference sequence. However, the variation in the protein sequence was restricted to the region between Residues 90 to 170. Thus, for the rest of the strains only the protein sequence corresponding to this region was compared (Fig. 3) . The multiple alignment of the partial A-protein sequences showed a variable region of approximately 80 amino acids flanked by more conserved regions. In addition to variation in amino acids between the sequences, insertions and deletions of amino acids resulted in varying sequence lengths, from 140 to 151 residues. Unfortunately, it was impossible to obtain sequences from the 2 subspecies reference strains salmonicida 4112 and pectinolytica 4113 with the primer-set used for the other strains. A similarity dendrogram describing the approximate grouping of the Aeromonas salmonicida strains based on comparison of the partial A-protein sequences is shown in Fig. 4 . The largest group contained 14 nearly identical sequences from atypical strains isolated from various fish species such as cod, halibut, turbot, spotted wolffish, char, salmon and whiting. Included was also the achromogenes reference strain 4111 and 4 of the 6 strains previously classified as achromogenes ( Table 2 ). The closest neighbouring group contained 4 strains from spotted wolffish and 1 from cod, while the atypical flounder strain 4122 was the most distantly related strain. The 2 salmonicida reference strains 4010 and 4014 were identical to the typical reference sequence, and grouped with the atypical strain 4123 from carp. The masoucida reference strain grouped with 2 strains from halibut and ling cod, and the smithia reference strain with 2 strains from goldfish and koi carp. There seemed to be no clear correlation between grouping of strains and fish species or geographical location. Several strains with identical partial A-protein sequences originated from different fish species and locations, such as the cod strain 4102 from Canada and the spotted wolffish strain 4119 from Norway, or the goldfish strain 4125 from USA and the koi carp Strain 4121 from Australia.
In order to compare vaccine efficacy, groups of spotted wolffish were vaccinated with atypical strains possessing serologically and genetically different Alayer proteins. The atypical Aeromonas salmonicida strains from spotted wolffish used as vaccine antigens were either Mab1B2-negative (4059, 4065 and 4067) or Mab1B2-positive (4128) ( Table 2 ). The vaccine ALPHA JECT™ 1200 containing a Mab1B2-positive strain was included for comparison. The vaccinated fish were challenged in parallel tanks with Mab1B2-negative Strain 4067, which was also used in 1 of the vaccines (Fig. 5) . The total mortality in the parallel tanks did not differ significantly (p = 0.7896), and the mortality in the control groups was 46 and 41%, respectively. In both tanks, the vaccines containing Mab1B2-negative strains gave the best protection, while the vaccines with Mab1B2-positive wolffish Strain 4128 or the ALPHA JECT strain appeared to be less efficient (Fig. 5) . A statistical comparison based on the results from both tanks demonstrated that all vaccines yielded significant protection (Table 3) . Vaccines containing Mab1B2-negative strains (4059, 4065 or 4067) did not differ from each other, but gave significantly better protection compared to vaccines with Mab1B2-positive strains (4128 or the ALPHA JECT strain), which did not differ from each other. M64655  MFKKTLIAAAIVVGSAAPAFADVVISPNDNTFVTTSLASVTKQPVLDFSTAQQNLTLNFS  60  4043  MFKKTLIAAAIVVGSAAPAFAHVVISPNDNTFVTTSLASVTKQPVLDFSTAQQNLTLHFS  60  4050  MFKKTLIAAAIVVGSAAPAFADVVISPNDNNFVTTSLASVTKQPVLDFSTAQQNLTLNFS  60  4065  MFKKTLIAAAIVVGSAAPAFADVVISPNDNTFVTTSLASVTKQTVLDFSTAQQTLTLNFS  60  4092 MFKKTLIAAAIVVGSAAPAFADVVISPNDNTFVTTSLASVTKQQVLDFSTAQQTLTLNFS 60 *********************.********.************ *********.***:** M64655 EVGDLKNNGFIVLEIQGEGQFNDAEIRQWLSNGFWRRPFTGLLVNPND---HGNF --ANS  115  4043  D-GDLKNNGFIVLEIQGEGQFNDAEIRKWLSNSVAGRSFTGLLVSATRNRIFANGVFVHS  119  4050  EVGDLKNNGFIVLEIQGEGQFNDAEIRQWLSNRFWRDPFTGLLVSPND---YGSR--GNS  115  4065  EVGDLKNNGFIVLEIQGEGQFNDAEIRQWLSNRYWNSSFTGLQVGPRT---FRNGSISNS  117  4092 EVGDLKNNGFIVLEIQGEGQFNDAEIRQWLSNRYWNSPFTGLLVGPRN---FRNG--ANS 115 : *************************:**** .**** GELNYVRQFFKIISDGTQQTIDHTIDKSGKRLRLALASDVETAA-VADQRVVLKLNLANQ 174 *.. *::*** ***:* ** ****..************* . : * .* ******* *  M64655  AFKLTSGSQGTVALTAGALWNASYTADPVATKPLFKLGKLFQLSLTNAGKATALVSEGFL  235  4043  AFKLTSGSQGTVSLTVGALWNASYTADPVATKPLFKLGKLFQLSLTNAGKATALVSEGFL  236  4050  AFKLTSGSQGTVALTAGALWNASYTADPVATKPLFKLGKLFQLSLTNGGKATALVSEGFL  234  4065  AFKLTSGSQGTVALTAGALWNASYTADPVATKPLFKLGKLFQLSLTNAGNAIALVSEGFL  236  4092 AFKLTSGSQGTVALTAGALWNASYTADPVATKPLFKLGKLFQLSLTNAGNAIALVSEGFL 234 ************:**.*******************************.*:* ******* *  M64655  KLNIGDANISATDFAITNVTTNQTIQRDKVNLTLTGDVSAFKKDANGNLVNKAGASIGWK  295  4043  KLDIGDANISATDFAITNVTTNQTIQRDKVNLTLTGDVSAFKKDANGNLVNKAGVSIGWK  296  4050  KLDIGDADISATDFAITNVTTNQTIQRDKVDLTLTGDVSAFKKDANGNLVNKAGVSIGWK  294  4065  KLDIRDADISATDFAITNVTTNQIIQRDKVNLTLTGDVSAFKKDANGNLVNKAGVSIGWK  296  4092 KLDIRDADISATDFAITNVTTNQTIQRDKVNLTLTGDVSAFKKDANGNLVNKAGVSLGWK 294 **:* **:*************** ******:***********************.*:** *  M64655  AAADGQSATAVLGAGNMAGGVQNALAAFGTLYVAADNTVPVPAVNFNVKAEIQGDSQATY  355  4043  AAADGQSATAVLGAGNMAGGVQDALAAFGTLYVAADNTVPVPAVNFNVKAEIQGDSQATY  356  4050  AAADGQSATAVLGAGNMAGGVQEALAAFGTLYVAADNTVPVPAVNFNVKAEIQGNSQATY  354  4065  AAADGQSATGVLGAGNMAGGVQDALAAFGTLYVAADNTVPVPVVNFNVKAEIQGDSQATY  356  4092 AAADGQSATGVLGAGNMAGGVQDALAAFGTLYVAADNTVPVPVVNFNVKAEIQGDSQATY 354 *********.************:*******************.***********:**** *  M64655  NYFKDELADLFILTRDGMKFDTITTGTTSANLIHIRDVSNILPTEGGKIFVTITEYADHA  415  4043  NYFKDELADLFILTRDGMKFDTITTGTTSANLIHIRDVSNILPTEGGKIFVTITEYADHA  416  4050  NYFKDELADLFILTRDGMKFDTITTGTTSANLIHIRDVSNILPTEGGKIFVTITEYADHA  414  4065  NYFKDELADLFILTRDGMKFDTITTGTTSANLIHIRDVSNILPTEGGKIFVTITEYADHA  416  4092 NYFKDELADLFILTRDGMKFDTITTGTTSANLIHIRDVSNILPTEGGKIFVTITEYADHA 414 *********************************************************** *  M64655  ANGRGEGTVLVTRKALSVTLPSGGAVTLKPADVAADVGASITAGRQARLVFEVETNQGEV  475  4043  ANGRGEGTVLVTRKALSVTLPSGGAVTLKPADVAADVGASITAGRQARFLFEVETNQGEV  476  4050  ANGRGEGTVLVTRKALSVTLPSGGAVTLKPADVAADVGASITAGRQARFLFEVETNQGEV  474  4065  ANGRGEGTVLVTRKALSVTLPSGGAVTLKPADVAADVGASITAGRQARFLFEVETNQGEV  476  4092 ANGRGEGTVLVTRKALSVTLPSGGAVTLKPADVAADVGASITAGRQARFLFEVETNQGEV 474 ************************************************::********** M64655 AVKKSNAEGVDIQNGTRGTAPLVDFTL 502 4043
AVKKSNAEGVDIQNGTRGTAPLVDFTL 501 ******* conserved. However, polyclonal antiserum raised against a typical A. salmonicda strain and adsorbed with atypical strains resulted in a great reduction of the titre, but significant reactivity remained, demonstrating antigenic differences among atypical and typical strains (Doig et al. 1993) . Our results show the deduced A-protein sequences of 5 strains to be very conserved (Fig. 2) apart from a variable region between Amino Acid Residues 90 and 170, which may be responsible for antigenic variation among the strains. The A-protein-specific polyclonal Ranti-A antiserum revealed 7 A-layer-deficient strains, including subspecies reference strains salmonicida (4010 and 4112) and masoucida (4110), previously reported to be A-layer-deficient (Austin et al. 1998) , the achromogenes (4111) and pectinolytica (4113) reference strains, and the atypical Strain 4102 from cod and Strain 4120 from salmon ( Table 2 ). The Aprotein-specific Mab1B2 reacted with all A-layer-producing strains except the smithia reference strain, 4 of 6 atypical strains from spotted wolffish, and flounder Strain 4122. The serological difference demonstrated by Mab1B2 is assumed to be in the variable region, since only minor amino acid differences were found in the remaining A-protein sequences, including both Mab1B2-positive and -negative strains (Fig. 2) .
Genome polymorphism demonstrated by AFLP-fingerprinting has previously been reported among atypical Aeromonas salmonicida strains (Lund et al. 2002a) , and was also confirmed in the present study. Some of the strains used in the previous study were included here in addition to other subspecies reference strains; 3 salmonicida subspecies reference strains appeared in the same cluster as an atypical strain from flounder, while the smithia and pectinolytica reference strains were unclustered. Of the 6 atypical strains classified as subspecies achromogenes (Table 2) , 5 clustered with the achromogenes reference, while in the previous study they clustered with a masoucida reference strain (Lund et al. 2002a ). This illustrates that AFLP-based grouping of atypical strains does not support the existing subspecies classification of A. salmonicida. There is no clear correlation between grouping of strains and fish species origin or geographical location, as was shown by AFLP fingerprinting of Vibrio viscosus, for which strains from Iceland and Norway appeared in different subgroups (Benediktsdottir et al. 2000) .
Surprisingly, grouping of Aeromonas salmonicida strains based on genome polymorphism was reflected in the similarity dendrogram based on a partial sequence of the single vapA gene (Figs. 1 & 4) . The large AFLPcluster (A) of 19 strains contained 2 sub-clusters, with 14 and 5 strains that were identical to the 2 neighbouring groups in the A-protein similarity dendrogram. The 4 wolffish strains in the AFLP sub-cluster possessed Mab1B2-negative A-layer proteins, while the cod strain 4102 was Mab1B2-negative because of its A-layer deficiency. Also, in both dendrograms, the smithia reference strain 4109 grouped with a halibut and ling cod strain. The partial A-protein sequences of the 2 salmonicida ref- The pectinolytica reference Strain 4113 was the most distant strain in the AFLP-based dendrogram, joining the other strains at a similarity of 10 to 15%, which may explain why no PCR-product was obtained from this strain. The PCR-product obtained from the subspecies salmonicida Strain 4112 was shorter than expected, and may contain a deletion in the vapA gene, which would explain why this strain is A-layer-deficient (Table 2 ) and why no DNA-sequence of the variable region could be obtained.
Vaccines containing Mab1B2-negative or -positive strains were compared in spotted wolffish challenged with a Mab1B2-negative strain. Although the challenge dose was comparable to that resulting in 94% mortality in the prechallenge experiment, only 46 and 41% mortality was obtained in the control groups in Tanks A and B, respectively. In contrast to the fish used for prechallenge, the control groups had received an injection of 0.9% NaCl in oil-adjuvant, which may have resulted in unspecific protection. However, an unspecific protection due to the oil-adjuvant alone was not observed in a previous experiment (Lund et al. 2002b) , and was the reason for not including 2 control groups in the present study, with one receiving 0.9% NaCl alone and the other receiving 0.9% NaCl in oiladjuvant. Despite the low mortality in the control groups, statistical analysis based on the results from both tanks demonstrated all vaccines to yield significant protection. However, the vaccines containing Mab1B2-negative strains resulted in a significantly better protection compared to the vaccines with Mab1B2-positive strains, including vaccine ALPHA JECT™ 1200. In a previous experiment, ALPHA JECT™ 1200 resulted in no protection of spotted wolffish challenged with a 100¥ higher dose (3.5 ¥ 10 3 cfu fish -1 ) of the same atypical Strain 4067 (Lund et al. 2002b) .
The protective antigens in the vaccines must be cellular, since only the bacterial cells of the bacterin were used in our experiments. Components of the cell surface are fundamental candidates as protective antigens in vaccines, since they form the initial contact Table 3 . Anarhichas minor. Vaccine efficacy as relative percent survival (RPS) in 2 tanks and statistical differences between vaccines when individually compared. Mortality in control group in the 2 tanks was 41 and 46%, respectively (ALPHA JECT™ 1200: furunculosis vaccine for salmon). between host and pathogen. The iron-binding outermembrane protein and a conserved porin have been reported to be protective (Hirst & Ellis 1994 , Lutwyche et al. 1995 . In addition, the A-layer has been shown to be an important protective antigen in oil-adjuvanted furunculosis vaccines for salmon (Lund et al. 2003) . Although many cellular antigens may vary among the strains used in the vaccines, the A-protein is the only antigen known to differ both serologically and genetically. The authors therefore questioned if serological differences in the A-protein could be responsible for the observed variation in vaccine efficacy in spotted wolffish (Lund et al. 2002b ). The deduced A-protein sequence of 4 atypical strains from various fish species revealed a sequence identity of 90 to 94% with the typical reference sequence. However, most of the sequences were highly conserved, apart from the region between Residues 90 and 170. Comparison of this A-protein region in the whole strain collection demonstrated a sequence identity of 70 to 100% with the typical reference sequence (GenBank M64655). If antibody responses towards the A-layer protein were important for protection, then differences in protection obtained with the various strains should correlate with the variable region of the A-protein. By the use of mimeotope analysis and electron microscopy using polyclonal and monoclonal antibodies, the surface topography of the A-layer was defined (Doig et al. 1993) . Inaccessible or non-epitopic residues accounted for 70% of the protein. While the strongly antigenically conserved C-terminal region contained most of the Alayer surface-accessible sequences, the N-terminal region contained the majority of the inaccessible residues. However, dispersed among these were 65 surface-accessible residues in 5 linear epitopic clusters, and 3 of these clusters appeared to be within the revealed variable region between Residues 90 and 170. Since, thus far, A-protein sequence variability appears to be restricted to a possible surface-exposed and immunogenic region, it is logical to consider it of importance. However, the vapA gene of additional typical and atypical strains should be fully sequenced to investigate the possibility of other variable regions of the A-protein. According to Høie et al. (1999) , 72 of 205 Aeromonas salmonicida strains did not produce PCR products with a primer-set targeting the C-terminal region of the A-protein, indicating sequence variation in this region.
Vaccine efficacy in different fish species may depend on the antigenic similarity between the Alayer protein of the vaccine and challenge strains of atypical Aeromonas salmonicida. Commercial salmon furunculosis vaccines have been shown to protect against infections with atypical A. salmonicida in salmon and cyprinid fishes (Jones et al. 1996 , Gudmundsdottir & Gudmundsdottir 1997 and in spotted wolffish (present study). ALPHA JECT™ 1200 was reported to protect halibut very well against experimental challenge with an atypical strain from cod (B. Gudmundsdottir pers. com.), but it gave poor protection against a natural outbreak of atypical furunculosis in a halibut farm in Norway (K. Gravningen, Alpharma AS, pers. com.). However, there is no data on the similarity between the A-layer proteins of the vaccine and the infecting strains in these cases. Thus, a possible correlation between serological and genetic differences in the A-protein among atypical strains of A. salmonicida and protection calls for further investigation.
